High and Persistent Anti-GM1 Antibody Titers Are Associated With Poor Clinical Recovery in Guillain-Barré Syndrome.

Robin C M Thomma,Christiaan Fokke,Christa Walgaard, Denise M C Vermeulen-de Jongh,Anne Tio-Gillen,Wouter van Rijs,Pieter A van Doorn,Ruth Huizinga,Bart C Jacobs

Neurology(R) neuroimmunology & neuroinflammation（2023）

引用 2|浏览6

暂无评分

摘要

High anti-GM1 IgG and IgM antibody titers at entry and persistent high anti-GM1 IgG antibody titers are associated with poor outcome in patients with GBS. Antibody persistency indicates ongoing antibody production long after the acute disease state in GBS. Further research is required to determine whether antibody persistency interferes with nerve recovery and is a target for treatments.

查看译文

关键词

antibody,poor clinical recovery,guillain-barr

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要